M. Tabrizizad
Impact in
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases
- Oncology top 10%
- CAR-T cell therapy research
Papers in
- Oncology 4
- CAR-T cell therapy research 4
-
- Phosphodiesterase function and regulation 1
- Co-authors
- Ben Powell (3 shared papers)Michael V. Milburn (2 shared papers)Catherine A. Luu (2 shared papers)Yoshihisa Suzuki (2 shared papers)Ryan Bremer (1 shared paper)Marina Zemskova (1 shared paper)Sheldon L. Holder (1 shared paper)Michael B. Lilly (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Journal of Clinical Oncology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Molecular Cancer Therapeutics (1 paper)Structure (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
M. Tabrizizad
8 papers receiving 820 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 184
- Oncology 213
- Molecular Biology 495
- Immunology 143
- Pathology and Forensic Medicine 104
Countries citing papers authored by M. Tabrizizad
This map shows the geographic impact of M. Tabrizizad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tabrizizad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tabrizizad more than expected).
Fields of papers citing papers by M. Tabrizizad
This network shows the impact of papers produced by M. Tabrizizad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tabrizizad. The network helps show where M. Tabrizizad may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Tabrizizad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 344 | |
| 2 | 2007 | 159 | |
| 3 | 2021 | 140 | |
| 4 | 2005 | 126 | |
| 5 | 2006 | 62 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 3 | |
| 8 | 2022 | 1 |
About M. Tabrizizad
M. Tabrizizad is a scholar working on Oncology, Molecular Biology, Immunology, Organic Chemistry and Surgery, having authored 8 papers that have together received 838 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (2 papers), Cancer Mechanisms and Therapy (1 paper), Estrogen and related hormone effects (1 paper), Nanowire Synthesis and Applications (1 paper), Synthesis and Biological Activity (1 paper) and Phosphodiesterase function and regulation (1 paper). The work is most often cited by research in Pharmacology (184 citations), Oncology (213 citations), Molecular Biology (495 citations), Immunology (143 citations) and Pathology and Forensic Medicine (104 citations). M. Tabrizizad has collaborated with scholars based in United States and France. Frequent co-authors include Ben Powell, Michael V. Milburn, Catherine A. Luu, Yoshihisa Suzuki, Ryan Bremer, Marina Zemskova, Sheldon L. Holder, Michael B. Lilly, Chao Zhang and Jonathan W. Neidigh. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer, Molecular Cancer Therapeutics and Structure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.